We conclude that during apoptotic DNA fragmentation, the H1 histones become rapidly dephosphorylated by a yet unknown protein phosphatase.
INTRODUCTION
During the last 5 years our understanding of the process of apoptosis has dramatically increased. This highly regulated form of programmed death of a eukaryotic cell can either be induced by neighboring cells via receptor-mediated activation of an apoptotic cascade, or by the cell itself, e.g. when irreversible DNA damage has been detected by cell cycle checkpoint control (reviewed in Refs. 1 and 2). Both forms of cell death share most of the signaling cascade mediated by caspases, and both forms finally result in a characteristic chromatin condensation, and later in the degradation of the cell into apoptotic bodies, subcellular particles which can be removed by neighboring cells. The signaling molecules which play major roles in the amplification and execution of cell death have been thoroughly investigated through the last years, and even first clinical attempts to manipulate these signaling cascades either to enhance or to reduce death in certain types of diseases have been made (3, 4) .
However, several aspects within the molecular mechanisms of programmed cell death are still enigmatic. Open questions concern the role as well as the putative rules of DNA cleavage within the process of apoptosis. The first observation of DNA fragments with the size of 180 -200 bp and multiples thereof in glucocorticoid-treated thymocytes was a hallmark in apoptosis research (5) . In the meantime, the visualization of the characteristic nucleosome (6) size DNA "ladder" is routinely used for the demonstration of apoptosis in many experimental cell systems including the one described here.
An apoptosis-specific DNase has been identified which seems to be responsible for the internucleosomal DNA cleavage (7, 8) . However, it is not fully understood whether apoptotic fragmentation of chromatin occurs randomly or whether this DNase termed CAD or DFF40 is capable of recognizing sites within the chromatin that determine preferential cleavage. In addition, the mechanisms as well as the biological function of internucleosomal DNA cleavage are still a matter of debate. On the other hand, it is well known that H1 histones are located at a position adjacent to the nucleosome core (reviewed in 9) where they might form a putative recognition site for the enzymatic attack of an internucleosomally cleaving DNase.
Thus, we were interested in determining whether the patterns of H1 histones and their posttranslationally modified forms change after induction of apoptosis and if so, whether these changes might play a role in the regulation of apoptotic DNA cleavage.
In this study we describe the rapid dephosphorylation of certain histone H1 subtypes shortly after induction of apoptosis and before the onset of internucleosomal cleavage. Since the H1 histones are positioned at a candidate site for the initiation of DNA fragmentation, and since it has been already demonstrated that H1 histones can greatly enhance CAD activity in vitro 
Induction of apoptosis
To induce apoptosis, the human leukemic cell line HL60 was treated with the topoisomerase I inhibitor topotecan (150ng/ml) for various times. The process of ongoing apoptosis was monitored by light microscopy and also by isolation of fragmented DNA from apoptotic cells after a method previously described (11) . The fragmented DNA from equal amounts of cells was applied onto a 1.5% agarose gel and separated electrophoretically.
To analyze the incorporation of phosphate into H1 histones after apoptosis induction, cells from parallel dishes were cultivated in phosphate-free RPMI for 2h, then treated with [³²P]-orthophosphoric acid (9.25MBq/ml medium) 1h prior to topotecan treatment. At various times, the cells were washed, and H1 histone subtypes were isolated as described (11) . Protein amounts of H1 from equal cell numbers were separated on a 12% polyacrylamide gel. The gel was fixed and stained with Coomassie blue, then scanned and subjected to autoradiography.
The autoradiography was analyzed densitometrically and the amount of incorporated [ 32 P] was calculated as percentage of the untreated control.
Purification of H1 histones by gel filtration
H1 histones were purified from histone solutions in 30 mM HCl (see above) by gel filtration (12, 13) . Briefly, solubilized H1 histones were applied onto a Biogel P60 column (Biorad, München, Germany). The application volume was approx. 2 ml, the total amount was approx. 100 µg. The column length was 350 mm, column width was 18 mm. After application, the column was eluted with 30 mM HCl at a constant flow rate of approx. 0.3 ml/min. 3.5 minfractions were collected, and 20 µl aliquots of all fractions were applied onto a 12.5% polyacrylamide gel and, after running the gel, it was stained with Coomassie blue for the analysis of the elution profile. Fractions containing H1 histones were pooled and, in the case of HL60 histone, concentrated by vacuum-drying and subjected to H1 subtype separation by HPLC.
High Performance Liquid Chromatography (HPLC) of H1 histones
The HPLC separation method was modified after a method described by Talasz et al. (14) to get a better separation of the comigrating human H1 subtypes H1.4 and H1.2. However, we have not achieved quantitative separation of human H1.4 from H1.2 using reversed phase HPLC. To increase the separation efficiency we used a relatively flat acetonitrile gradient and manual fraction collection. The HPLC unit was a Kontron 450 MT2 system, equipped with a M 420 pump, a M 425 gradient former and a M 432 variable wavelength detector. 100 µl of total P60-purified H1 histones with a concentration of 100-1,000 µg/ml solubilized in 30 mM
HCl were loaded onto a Zorbax 300SB-C18 column (4.6 x 250 mm, 5 µm particle size; Agilent Technologies, Waldbronn, Germany). Samples were eluted at a constant flow of 1 ml/min and absorbance of the effluent was monitored at 210 nm. Recombinant human H1 histone H1.2 was prepared from transformed yeast as described (11, 21) and purified by P60 gel filtration as described above. H1. 
Analysis of fragmented DNA by agarose gel electrophoresis
For the preparation of fragmented DNA, cells were harvested and washed as described for the purification of histone H1 proteins. Preparation of fragmented DNA has been described in (11) . Briefly, cell pellets were incubated on ice for 30 min in 450 µl lysis buffer (0.2% Triton X-100 in 10 mM Tris/10 mM EDTA, pH 8.0). Samples were microcentrifuged (11,600 g for 10 min at 4°C) and the non-sedimentable DNA fragments of the supernatants were 
HPLC separation of H1 histones and subsequent CZE analysis allows quantification of phosphorylation rates of individual H1 histone subtypes
The CZE analysis of H1 histones from untreated versus topotecan-treated HL60 cells had revealed that modified and unmodified forms of H1 subtypes contribute to the total H1 pattern (11) . We therefore separated the major H1 histone subtypes present in HL60 cells by reversed phase HPLC before CZE (see Experimental Procedures). With this technique, we could quantitatively separate H1.5 from H1.4 and H1.2 ( Fig. 2A) . Moreover, we achieved a substantial separation of H1.2 from H1.4, as demonstrated by PAGE in Fig. 2B . This HPLC fractionation allowed us to reanalyze the individual H1 subtypes by CZE (Fig. 2C) as a prerequisite for the interpretation of the electropherograms we obtained with total H1 histone preparations (e.g. in Fig. 3A) .
Since the data shown in Fig.1 indicate a dephosphorylation of H1 histones after topotecan treatment, we tried to prove whether the additional peaks of the H1 subtypes shown in Fig. 2C indeed reflect phosphorylated forms of the individual subtypes. Therefore we performed in vitro protein kinase assays using recombinant human cyclin-dependent kinase 1 (cdk1) and protein kinase Cα (PKCα) and recombinant human histone H1.2 as a substrate. The subsequent analysis of the phosphorylation products was done by CZE. As shown in Unexpectedly, the H1 subtypes of untreated cells strongly differed in their phosphorylation state, in a way that H1.5 and H1.4 were up to 3 times phosphorylated, with a maximum of once and twice phosphorylated forms, whereas H1.2 seemed to be only phosphorylated once.
Whether this phosphorylated form of H1.2 is phosphorylated preferentially at a defined serine or threonine residue or whether it represents a mixture of differently, but only once, phosphorylated forms, remains to be determined by tryptic digestion and mass spectrometry analysis of the resulting peptides (see Discussion).
We performed the same experiment with topotecan-treated cells to analyze the rate of dephosphorylation of individual histone H1 subtypes as indicated by the labeling experiments shown in Fig. 1 . H1 histones from 4 x 10 9 HL60 cells treated for 8 h with 150 ng/ml topotecan were extracted, purified by gel chromatography and the H1 subtypes were separated by HPLC ( Fig. 2A, right panel) . The peaks eluting from the HPLC were collected and the individual H1 subtypes were analyzed by PAGE (Fig. 2B , lower panel) and capillary electrophoresis (Fig. 2C, lower panel) . As expected from the experiment shown in Fig. 1, all 3 histone H1 subtypes showed a massive reduction of their phosphorylated subtypes upon topotecan treatment; leading to a relative increase of the respective unphosphorylated forms.
The HPLC peak representing H1.4 showed two additional peaks when analyzed by CZE.
However, since the separation of H1.4 from H1.2 by HPLC is incomplete, there is an overlay of residual H1.2 with twice phosphorylated H1.4 within the peak eluting last in the electropherogram of H1.4 (see overlay in Fig. 2C, lower panel) , making it impossible to quantify the amount of twice phosphorylated H1.4 within the preparation. However, the phoshorylation seen in untreated HL60 cells appears to be, at least partially, H1 subtypespecific (see above), whereas the dephosphorylation differs only in its extent with respect to individual histone H1 subtypes.
H1 subtype dephosphorylation precedes nucleosomal DNA fragmentation
HL60 cells were incubated in the presence of 150 ng/ml topotecan for different times. After incubation, the cell cultures were split and half the cells were used for the extraction of H1 histones while the other half served as a source for the preparation of fragmented DNA. H1 histones were then purified as described in the Experimental Procedures section and further analyzed by capillary zone electrophoresis, as described in (11) . The identification of unmodified histone H1 subtypes had been previously shown by mixing the preparations from cell lines with recombinant proteins purified from transformed yeast (21) . Mixing e.g. H1.2 with the H1 preparation from human cell lines had resulted in the selective increase of one single peak, indicating that this peak represents H1.2 within the mixed preparation. These mixing experiments had been done with all human recombinant subtypes except H1t which is exclusively expressed in the testis (22) Procedures section. The fragmented DNA was purified by organic extraction and electrophoretically separated on a 1.25% agarose gel. The gel was stained with ethidium bromide and digitally imaged (Fig. 3B) .
The CZE analysis revealed that already 45 min after topotecan treatment, a significant change in the total H1 subtype pattern could be observed, leading to an increase in the amounts of unmodified H1 subtypes H1.4 and H1.5, whereas other peaks presumably representing phosphorylated H1 subtypes simultaneously decreased (Fig. 3A) . However, nucleosomal DNA fragments could not be detected before 3 h of topotecan treatment (Fig. 3B) This indicates that the putative protein phosphatases or protein kinase inhibitors which are responsible for the dephosphorylation of H1 histones after apoptosis induction may be activated by a mechanism which acts upstream of the caspase 3-dependent activation of CAD/DFF40.
DNA fragmentation as mediated by topoisomerase I inhibition is diminished by simultaneous protein phosphatase inhibition
To determine if the dephosphorylation of H1 histones in the course of apoptosis induction could be influenced by phosphatase inhibition, we treated the cells with the phosphatase inhibitor calyculin A, a substance which is about equally potent in inhibiting type 1 and 2 protein phosphatases. Incubation of HL60 cells with a concentration of 30 nM Calyculin A for 8 h resulted in a significant hyperphosphorylation of H1 histones (Fig. 4F) . We then were interested in determining whether protein phosphatase inhibition could influence the sensitivity of HL60 cells towards apoptotic inducers such as topotecan. We therefore treated the cells for 8 h with increasing concentrations of calyculin A (3, 10, 30 nM) and simultaneously with a constant concentration of topotecan (150 ng/ml). After treatment, the cells were washed and subjected to the extraction of H1 histones on one hand as well as analysis of DNA fragmentation on the other hand. We observed that the lower molecular weight DNA fragmentation caused by topotecan treatment was diminished in the presence of 3 nM of calyculin A and higher molecular weight fragments remained in the upper parts of the respective lanes (Fig. 4G ). Moreover, with higher concentrations of calyculin A we observed a reduction in the total amount of fragmented DNA per given cell number suggesting that internucleosomal DNA fragmentation is reduced by simultaneous protein phosphatase inhibition.
The pattern of H1 histones showed an increase in peaks putatively representing (Figs. 4C-E) . This hyperphosphorylation could be observed with 3 nM of calyculin A but was more pronounced with higher concentrations. The pattern observed with 30 nM of calyculin A and 150 ng/ml of topotecan (Fig. 4E) was very similar to that with 30 nM of calyculin A alone (Fig. 4F) , implying that the effect of protein phosphatase inhibition, leading to a dramatic hyperphosphorylation of H1 histones, was dominant over the dephosphorylating effect of topotecan treatment.
Activation of protein kinase C (PKC) by PMA treatment also inhibits apoptotic DNA fragmentation
The role of protein kinase C activation within the signaling process of apoptosis has been discussed in the literature rather controversially (reviewed in 23). Pro-apoptotic as well as a series of anti-apoptotic effects have been reported, depending on the different tissue model systems (24, 25) . We therefore were interested in the effects of protein kinase C activation on DNA fragmentation and apoptosis as induced by the inhibition of topoisomerase I. HL60 cells were treated with 100 ng/ml PMA, 150 ng/ml topotecan or both substances for 6 h. After incubation, H1 histones and fragmented DNA were isolated as described. The results are shown in Fig. 5 .
It is obvious that PMA treatment resulted in an overall increase of the relative amount of phosphorylated H1 subtypes, leading to a decrease of the peaks representing the unphosphorylated H1 histones H1.4 and H1.5, while the latest peak representing mainly monophosphorylated H1.2 increased (Fig. 5B) . Treatment of the cells with both PMA and topotecan (Fig. 5D ) led to a CZE pattern which highly resembled the pattern obtained with topotecan alone (Fig. 5C,) , indicating that in this case, the dephosphorylating effect of topotecan is dominant over the induction of H1 phosphorylation by PMA. Regarding the DNA fragmentation pattern (Fig. 5E ) PMA alone did not induce DNA fragment formation by itself, but instead was capable of reducing the DNA fragmentation capacity of topotecan. This suggests that in the HL60 promyelocytic cell line the induction of protein kinase C as the main target of PMA has anti-apoptotic effects which are not correlated with the capacity to increase histone H1 phosphorylation.
The PKC inhibitor staurosporine reduces H1 phosphorylation and induces apoptosis and

DNA cleavage
The protein kinase C inhibitor staurosporine has been reported to be a potent apoptosis inducer in several cell lines, including HL60 cells (26) . We were therefore interested in the effects of staurosporine on the histone H1 phosphorylation pattern as well as on the DNA fragmentation pattern. As shown in Fig 6F, a 2 h treatment with 0.3 µM staurosporine was capable of inducing DNA fragmentation in HL60 cells. At the same time, the phosphorylation levels of all H1 subtypes were greatly reduced (Fig. 6B) . At 6 h of staurosporine treatment, the peak representing mainly once phosphorylated histone H1.2 became very small (Fig. 6D ).
In this case, there is, as in the case of treatment with topotecan, a strong correlation of the extent of histone H1 dephosphorylation with the occurrence of nucleosomal DNA fragments.
However, it is not clear whether the apoptosis inducing capacity and the histone phosphorylation reducing capacity of staurosporine are also mechanistically correlated.
DISCUSSION
The family of H1 histones consists of 7 subtypes, termed H1.1 to H1.5, H1° and H1t (27) , of which the proteins H1.2 and H1.4 are the predominant subtypes in most human cell lines (14, 28) . They are very basic proteins which exert their structural roles in interacting with DNA at defined positions (29) , thereby organizing higher order structures as mostly evident in the case of the highly compacted and organized chromosomes during mitosis (30) . Moreover H1 histones serve several functional roles, mainly in regulating the accessibility of transcription factors to DNA (reviewed in 31, 32). The members of the H1 family are closely related and have very few differences in their amino acid sequence, which makes it a difficult task to separate them by standard methods of analytical chemistry.
Since the condensation of chromatin is a very significant step during the process of cellular apoptosis, and since H1 histones are thought to be the major regulator proteins of, at least, mitotic chromatin condensation, we were interested in exploring the roles of H1 histones for the process of apoptotic chromatin condensation and fragmentation. We therefore started to comparatively analyze the composition of the histone H1 protein pattern of normally growing and of apoptotic human tumor cells. By analyzing H1 histones by CZE, we initially observed a very rapid change in the overall H1 subtype pattern, leading to an increase of the peaks representing unmodified subtypes, mainly H1.5 and H1.4, whereas other subtypes remained more or less constant. However, by using capillary electrophoresis alone it was not possible to identify the nature of histone H1 subtype modifications (11) . We show here that there is a very strong correlation between the occurrence of internucleosomal DNA fragmentation in the course of apoptosis of human leukemic cells and a massive dephosphorylation of all H1 histone subtypes that could be isolated from these cells. Since the dephosphorylation precedes the DNA fragmentation, and since inhibitors of H1 dephosphorylation also inhibit DNA fragmentation, the activation of a putative protein phosphatase responsible for the H1 dephosphorylation after apoptosis induction could be located upstream of the caspase 3-mediated activation of CAD, the enzyme putatively responsible for the generation of nucleosomal fragments. On the other hand, our data show that although activation of PKC by PMA was able to reduce the DNA fragmentationinducing effect of topotecan, the histones were nonetheless dephosphorylated, indicating that the dephosphorylation of H1 histones is not a sufficient prerequisite in the activation process of CAD.
Within the sequences of H1 histones there is a variety of putative phosphorylation sites; e.g. histone H1.4 has one potential phosphorylation site for Ca 2+ -Calmodulin-dependent kinase II, seven sites for casein kinase I, two for Glycogen-stimulated kinase 3, five sites for kinases of the cyclin-dependent kinase (cdk) family, two sites for protein kinase A, six sites for protein kinase C and two sites for protein kinase G (computationally predicted phosphorylation sites, partially overlapping, source: http://www.cbs.dtu.dk/htbin/pbasepredict.htm). Evidently not all these sites are phosphorylated in vivo. Our data with the broad-specificity protein kinase C activator PMA as well as with the protein kinase C inhibitor staurosporine argue towards a participation of members of the protein kinase C family in the process of H1 histone phosphorylation. However, it is unclear whether this is a direct or indirect involvement. Moreover, it is unknown whether the strong pro-apoptotic effects of staurosporine (26) as well as the protective effect of PMA in HL60 cells are directly correlated with the abilities of these substances to modulate protein kinase C activity (33) .
Additional experiments showed that more specific PKC inhibitors (e.g. Goe 6976, which is specific for the inhibition of the conventional PKC isoforms) had no pro-apoptotic effect and also no inhibitory effect on H1 phosphorylation, indicating that members of the novel PKC or the atypical PKC subfamilies or even unrelated protein kinases could be involved in these pathways (data not shown).
The identities of specific physiological H1 phosphatases have also not been ruled out yet.
Although several reports describing H1 phosphatase activities have been published, the results are rather controversial. Some authors have indications for a protein phosphatase 2A activity in post-mitotic (34) or in apoptotic (35) cells, other groups have shown evidence for phosphatase type 1 being at least the protein phosphatase responsible for the H1 dephosphorylation at the end of mitosis (36) . In radiation-treated human cells, also a rapid dephosphorylation of H1 histones has been observed, although the authors could not discriminate between phosphatase 1 and phosphatase 2A being responsible for this dephosphorylation (37) .
There are also evident differences in the degree of phosphorylation of individual H1 subtypes of control HL60 cells as well as in the degrees of their dephosphorylation after apoptosis induction. The subtype H1.2 has 4 potential phosphorylation sites for protein kinases of the cdk family (motif: S/T-P-X-K). Although the subtypes H1.4 and H1.5 have only one more cdk phosphorylation site (located at the C-terminus of the peptides), they are in vivo up to three times phosphorylated, whereas H1.2 is only phosphorylated once. Consequently, this single phosphorylation site of H1.2 is nearly completely dephosphorylated upon apoptosis induction, leading to a strong reduction of the latest peak in electropherograms of total H1 preparations from apoptotic cells (see Fig. 3A ), whereas the other two subtypes still show a moderate phosphorylation level. In addition to these in vivo studies, we have performed in vitro phosphorylation assays with recombinant human histone H1.2 and with cdk1 and PKCα as protein kinases. Under these conditions, H1.2 could be phosphorylated at multiple sites (Fig. 2D) . The reason for this discrepancy between in vitro and in vivo phosphorylation levels is unclear. However, one could speculate that in vivo, regulatory proteins selectively interact with parts of the H1.2 molecule, thereby masking some of the phosphorylation sites for protein kinases of the cdk family, resulting in a single phosphorylation event. Experiments with mass spectrometric analysis of tryptic peptides from H1.2, H1.4 and H1.5 are planned to prove this hypothesis. In Tetrahymena, the phosphorylation sites of macronuclear H1 have been mapped and also mutated. Even when all 5 hydroxyamino acid sites were changed to alanines, the viability of this organism was not significantly altered, indicating that the phosphorylation seems to be dispensable in this protozoan organism (38) .
Recently, a series of reports from different groups described the initial phosphorylation of distinct core histones after apoptosis induction in different cellular model systems. The first observation was that treatment with the fungal toxin gliotoxin leads to a rapid phosphorylation of histone H3 at Ser-10 in thymocytes (39) . In this case, the authors showed evidence for protein kinase A being involved in that apoptotic phosphorylation step. The phosphorylation of the core histone subtype H2A.X has also been reported to be closely correlated with the initiation of DNA fragmentation in Jurkat and HL60 cells (40, 41) . This phosphorylation is mainly restricted to one position at Ser-139 and can be inhibited by simultaneous transfection of the cells with the inhibitor of CAD, ICAD. The authors postulate that the phosphorylation of H2A.X could be mechanistically correlated with the initiation of apoptotic DNA cleavage.
In addition, an apoptosis-correlated phosphorylation of histone H2B has been demonstrated in a series of human cell lines, including HL60 cells (42) . However, the author could not find any major changes in the phosphorylation state of other histones, including the histones H3, H2A.X, and also histone H1. This is in contrast to the data presented here, as well as to the data concerning changes in the phosphorylation state of other core histones mentioned above. A stimulatory role for H1 histones in the process of CAD-mediated DNA fragmentation in vitro has already been shown twice (10, 43) . However, it is unclear whether different H1 subtypes and/or differentially phosphorylated forms of H1 histones have specific influences on CAD activity. On the other hand, a role of changes in the phosphorylation state of H1 histones in another process of chromatin reorganization, namely in mitotic chromatin condensation has been proposed for a long time. Several reports provide evidence for kinases of the cdk family being involved in mitosis-specific phosphorylation (44) which in turn seems to be a prerequisite for the correct compaction of metaphase chromosomes (45) . Thus, the structural changes within the nucleosomal organization of chromatin seem to depend, at least in part, on the location and numbers of hydroxyamino acid phosphorylations within the H1 molecule. It is not clear however, which sites of individual H1 histone subtypes are obligatorily phosphorylated during mitosis, and consequently, which sites have to get dephosphorylated in order to correctly complete anaphase and cytokinesis.
We have shown here that there is a strong correlation between initial apoptotic H1 dephosphorylation and the onset of apoptotic DNA fragmentation, implying that indeed the phosphorylation state of H1 histones in situ located within the chromatin might also be important for the processes of chromatin condensation and/or chromatin fragmentation.
Further studies are initiated to bring more light into the role of H1 histones for the biochemical execution of cell death. (Fig. 1A) . DNA size marker (indicated with "M" in the Figure) was from GibcoBRL, Karlsruhe, Germany. It consisted of fragments between 500 and 3500 bp in steps of 250 bp and an additional fragment of 5000 bp. The bands corresponding to the 1000 and 5000 bp fragments, respectively, were brighter than the others to provide internal orientation.
In parallel, HL60 cells were pretreated with [³²P]-orthophosphoric acid for 1 h and then treated with topotecan as described in Experimental Procedures. At the indicated times H1 histones were purified as described. Protein amounts of H1 from equal cell numbers (10 5 ) were separated on a 12% polyacrylamide gel. The gel was fixed and stained with Coomassie Blue (Fig. 1B ) and subjected to autoradiography (Fig. 1C) (Fig. 1D) . Identical aliquots of each three samples were subjected to PAGE, then the gels were stained with Coomassie Blue (Fig. 2B ). Other aliquots were subjected to CZE using a fused-silica capillary with a total length of 122 cm and an inner diameter of 50 µm. Absorbance data at 200 nm were continuously recorded. Figure 2C shows the electropherograms of the separated H1 subtypes as well as overlays of the individual subtype electropherograms from untreated ("control"; upper 4 panels) as well as topotecan-treated ("topo"; lower 4 panels) cells. . Figure 4G shows aliquots of internucleosomally cleaved DNA corresponding to 5 x 10 6 cells separated on a 1.2% agarose gel and visualized by ethidium bromide staining. Marker bands are as above (see Figure 3B ).
Figure 5
The protein kinase C activator PMA also inhibits topotecan-mediated DNA fragmentation but does not attenuate topotecan-mediated H1 dephosphorylation 10 8 HL60 cells were treated with 100 ng/ml PMA (Fig.5B) , 150 ng/ml topotecan ( 
